NeuroMetrix, Inc. Announces Date for 2007 Fourth Quarter Financial Results Conference Call

NeuroMetrix, Inc. (Nasdaq: NURO) today said it plans to issue its 2007 fourth quarter financial results before the opening of the market on Tuesday, February 12, 2008. The Company’s management team will host a conference call and webcast at 10:00 A.M. Eastern time, on the same day, to discuss the Company’s financial results for the fourth quarter ended December 31, 2007 and business and financial developments and trends affecting the Company. In addition, the Company will be available to answer questions concerning business and financial matters affecting the Company. Management has elected to schedule its 2007 fourth quarter financial results conference call after the upcoming American Medical Association ("AMA”) CPT editorial panel meeting, which is scheduled to take place from February 7-10, 2008. One of the agenda items at the AMA meeting is a review of the reimbursement coding for nerve conduction studies. The conference call may be accessed in the United States by dialing 866-383-7998 and using the confirmation code 29739356. Internationally, the conference call may be accessed by dialing 617-597-5329 and using the same confirmation code. The webcast, along with the earnings press release and accompanying condensed financial statements, will be accessible from the Company’s website at www.neurometrix.com under the "Investors” tab. A replay of the conference call will be available starting two hours after the call by dialing 888-286-8010, domestically and 617-801-6888, internationally. The confirmation code to access the replay is 21768121. The replay will be available for three months after the conference call. About NeuroMetrix NeuroMetrix is a medical device company advancing patient care through the development and marketing of innovative products used to diagnose and treat diseases of the nervous system, neurovascular disorders, and pain. To date, our focus has been on the diagnosis of neuropathies and neurovascular disorders. Neuropathies are diseases of the peripheral nerves and parts of the spine that frequently are caused by or associated with diabetes, low back pain and carpal tunnel syndrome, as well as other clinical disorders. The NC-stat System, the Company's neuropathy diagnostic system, has been on the market since May 1999 and is used in over 5,500 physician's offices and clinics in the United States. Diabetic retinopathy is a common neurovascular complication of diabetes and the leading cause of blindness among working age adults. The Company recently acquired EyeTel Imaging and their product, the DigiScope, which is a retinal imaging system specifically designed for use at the point-of-care in physician offices and vision clinics.